Tổng số lượt xem trang

Thứ Bảy, 3 tháng 2, 2018

FDA clears SuperSonic's Aixplorer for liver disease

This clearance covers specific ultrasound imaging capabilities related to liver disease, and will allow clinicians to use Aixplorer to assess hepatic fibrosis and steatosis, the company said.

Aixplorer systems image and measure liver and spleen stiffness in real time under image guidance, using SuperSonic Imagine's shear-wave elastography technology. Liver and spleen stiffness are known to be correlated to liver fibrosis severity and are therefore considered key noninvasive markers of disease severity, according to the firm.